---
figid: PMC4324342__conc-22-33f2
figtitle: Classes of pi3k/Akt/mtor signalling pathway inhibitors in breast cancer
  phase i, ii, and iii clinical trials
organisms:
- Homo sapiens
pmcid: PMC4324342
filename: conc-22-33f2.jpg
figlink: /pmc/articles/PMC4324342/figure/f2-conc-22-33/
number: F2
caption: Classes of pi3k/Akt/mtor signalling pathway inhibitors in breast cancer phase
  i, ii, and iii clinical trials. The dashed line indicates negative feedback. pi3k
  = phosphatidylinositol 3 kinase; pip = phosphatidylinositol-4 phosphate; pten =
  phosphatase and tensin homolog; Akt = v-akt murine thymoma viral oncogene; mtor
  = mammalian target of rapamycin; tsc = tuberous sclerosis; s6k = S6 kinase; 4ebp1
  = 4E-binding protein.
papertitle: Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor
  pathway for the treatment of breast cancer.
reftext: S. Chia, et al. Curr Oncol. 2015 Feb;22(1):33-48.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9509268
figid_alias: PMC4324342__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4324342__F2
ndex: ba34ba4a-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4324342__conc-22-33f2.html
  '@type': Dataset
  description: Classes of pi3k/Akt/mtor signalling pathway inhibitors in breast cancer
    phase i, ii, and iii clinical trials. The dashed line indicates negative feedback.
    pi3k = phosphatidylinositol 3 kinase; pip = phosphatidylinositol-4 phosphate;
    pten = phosphatase and tensin homolog; Akt = v-akt murine thymoma viral oncogene;
    mtor = mammalian target of rapamycin; tsc = tuberous sclerosis; s6k = S6 kinase;
    4ebp1 = 4E-binding protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - ADA2
  - MTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - CRTC2
  - CRTC1
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - RPS6KB1
  - RPTOR
  - EIF4EBP1
  - Tyrosine
  - Cancer
---
